Prescription digital therapeutic developer Theranica announced it had received FDA 510(k) clearance to use its Nerivio device for migraine prevention in patients 12 and older. The wearable is worn around the upper arm and controlled…
Continue Reading
Anne Kim, Co-Founder and CEO of Secure AI Labs (SAIL)Clinical research is only as good and thorough as the data that’s available — and we need to do a better job of making that…
Continue Reading
What You Should Know:– Today, the AI-powered genetic testing and precision medicine company Tempus announced that it has signed a significant strategic agreement with Pfizer to more precisely gather insights that will inform novel drug discovery…
Continue Reading
Israel-based AION Labs, an AI-enabled drug discovery partnership between global pharma and tech companies, announced the launch of its second startup, DenovAI.DenovAI will develop an AI-enabled computational biophysics platform that can discover potential antibodies…
Continue Reading
Aptinyx’s approach of treating neurological disorders by targeting a key receptor in the brain has fallen short again, this time in Parkinson’s disease. With its third clinical trial failure in less than a year,…
Continue Reading
Community doctors are underrepresented in clinical trials, meaning their patients are too. How can community practices become centers of excellence for research and provide better overall healthcare and treatment opportunities for the patients they…
Continue Reading
Cough, fever, and breathing difficulty could signal a Covid-19 infection. It could also be the flu. A Lucira Health diagnostic is now the first one authorized by the FDA to identify the culprit virus…
Continue Reading
A Fulcrum Therapeutics clinical trial testing a potential sickle cell disease drug has been paused by the FDA. With the clinical hold on the early-stage study, Fulcrum becomes the fourth company with a stalled…
Continue Reading
What You Should Know:– ObvioHealth launches proprietary application programming interface (API) tailored specifically for digital therapeutics (DTx) clinical trials.– ObvioHealth’s API ensures tight integration between the digital therapeutic and the ObvioGo platform, providing sponsors…
Continue Reading
Hemophilia A patients manage the chronic disorder with infusions administered as frequently as every two to three days. The FDA has approved a Sanofi drug designed to last longer in the body, giving patients…
Continue Reading
